when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Marketed
pegfilgrastim
Udenyca (pegfilgrastim-cbqv)
Febrile Neutropenia Accord Biopharma Inc
Preclinical
pegfilgrastim biosimilar
Fylnetra (pegfilgrastim-pbbk)
Unspecified Cancer Meitheal Pharmaceuticals Inc
Marketed
peginterferon alfa-2a
Pegasys (peginterferon alfa-2a)
Hepatitis B pharmaand GmbH
Marketed

page 242 of 271

peginterferon beta-1a

Plegridy (peginterferon beta-1a)

Progressive Relapsing Multiple Sclerosis (PRMS)

$BIIB BIOGEN INC.

Phase 3

peginterferon lambda-1a

peginterferon lambda-1a

Coronavirus Disease 2019 (COVID-19) Eiger Inno Therapeutics Inc

Marketed

Krystexxa (pegloticase)

Gouty Arthritis (Gout) Horizon Therapeutics USA Inc

Phase 1

pegmispotide[INN]

Ulcerative Colitis Adiso Therapeutics Inc

Phase 3

Metabolic Dysfunction-Associated Steatohepatitis (MASH or… 89bio Inc

Phase 2

pegsebrenatide [INN]

Multiple Sclerosis Neuraly Inc

Phase 2

pegtarazimod hydrochloride

pegtarazimod hydrochloride

Chronic Obstructive Pulmonary Disease (COPD) ReAlta Life Sciences Inc

Phase 3

Homocystinuria$TVTX Travere Therapeutics, Inc.

Phase 3

pegunigalsidase alfa

Elfabrio (pegunigalsidase alfa)

Fabry Disease Chiesi Farmaceutici SpA

Marketed

Palynziq (pegvaliase [INN])

Hyperphenylalaninemia$BMRN BIOMARIN PHARMACEUTICAL INC

Marketed

Somavert (pegvisomant)

Acromegaly$PFE PFIZER INC

Phase 3

Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)$NVS NOVARTIS AG

Phase 2

Reolysin (pelareorep)

Human Epidermal Growth Factor Receptor 2 Negative Breast…$ONCY ONCOLYTICS BIOTECH INC

Phase 2

pelcitoclax [INN]

Neuroendocrine Tumors$AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL

Phase 2

Cervical Cancer ISA Pharmaceuticals BV

Phase 2

Neuroendocrine Carcinoma Phanes Therapeutics Inc

Phase 3

pemafibrate [INN]

Hypertriglyceridemia Kowa Co Ltd

Phase 2

pemafibrate + tofogliflozin

pemafibrate [INN] + tofogliflozin

Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Kowa Co Ltd

Phase 1

pembrolizumab biosimilar

Melanoma Formycon AG

Marketed

Pemfexy (pemetrexed [INN])

Malignant Pleural Mesothelioma Eagle Pharmaceuticals Inc

Marketed

pemetrexed tromethamine

Pemetrexed Ditromethamine (pemetrexed tromethamine)

Malignant Pleural Mesothelioma Hospira Inc

Marketed

Pemazyre (pemigatinib)

Metastatic Bile Duct Cancer$INCY INCYTE CORP

Marketed

Pemgarda (pemivibart)

Coronavirus Disease 2019 (COVID-19)$IVVD Invivyd, Inc.

Phase 2

Alcohol Use Disorder (AUD)$ALT Altimmune, Inc.

Phase 1

Vasomera (pemziviptadil [INN])

Cystic Fibrosis ImmunoForge Co Ltd

Marketed

Herpes Labialis (Oral Herpes) Padagis LLC

Marketed

penciclovir sodium

Penciclovir Sodium

Herpes Labialis (Oral Herpes) Torrent Pharma Inc